Browse Liposomes topic

Subtopics (9)

Articles

1-34 out of 34 article(s)

Title	Author	Type	Date	Words
16. Specific targeting of liposomes functionalized with mistletoe lectin I.	Bunjes, V.; Winkler, K.; Peschka-Suss, R.; Schubert, R.	Brief article	Oct 1, 2007	280
Oligonucleotide delivery with serum into HeLa cells using polycation liposomes.	Mady, Mohsen M.	Clinical report	Mar 1, 2007	3254
Long-lasting liposomes.		Brief article	Apr 29, 2006	194
Valentis announces settlement of PEG-liposome patent infringement.		Brief Article	Jul 1, 2003	287
NeoPharm to present liposome technology data.			Oct 1, 2002	588
University of California obtains United States patent.		Brief Article	Apr 1, 2002	68
Valentis files suit against Alza for patent infringement.		Brief Article	Apr 1, 2001	273
Institut Francais du Petrole obtains United States patent.			Dec 1, 1999	61
Endovasc to Run Second Pilot Product for New Prostaglandin E-1 "LLPGE-1".		Article	Jul 23, 1998	187
Harvard Scientific Files Form 10K.			Mar 20, 1998	434
DepoTech Receives Notice of Allowance for Drug Delivery Patent.			Nov 19, 1997	471
NeXstar Pharmaceuticals, The Liposome Co., Settle Patent Litigation.			Aug 11, 1997	334
Harvard Scientific concludes first round of financing and accelerates development of its proprietary treatment for male erectile dysfunction.			Apr 3, 1997	323
SEQUUS Pharmaceuticals announces supplemental new drug application for AMPHOTEC.			Mar 12, 1997	730
Protein Sciences and SEQUUS Pharmaceuticals to partner on the development and production of Liposome-CD4 for the treatment of HIV/AIDS.			Jan 28, 1997	373
Endorex Corporation Signs Definitive Licensing Agreement with MIT for Oral Drug Delivery Technology.			Dec 19, 1996	641
Harvard Scientific Corp. relocates under new executive management.			Dec 17, 1996	397
SEQUUS PHARMACEUTICALS ANNOUNCES INTERNATIONAL MARKETING AGREEMENT WITH SCHERING-PLOUGH CORPORATION FOR CAELYX.			Sep 25, 1996	751
SEQUUS Pharmaceuticals' Stealth Liposomes Localize Specifically in Solid Tumor Tissues.			May 21, 1996	380
NeXstar Pharmaceuticals launches DaunoXome (daunorubicin citrate liposome injection).			Apr 30, 1996	442
FDA approves DaunoXome as first-line therapy for Kaposi's sarcoma.			Apr 9, 1996	471
Microfluidics International announces sale of its Dermasome products business.			Jan 22, 1996	296
AmBisome gains marketing approval in Egypt.			Jan 11, 1996	196
Harvard Scientific Corp. completes $1 million institutional private placement of its shares.			Jan 9, 1996	226
Majority shareholder increases holdings in Harvard Scientific to over 80%.			Dec 11, 1995	235
NeXstar receives patent for tumor-targeting liposomes.			Jul 26, 1995	339
Baywood International Inc. enters into Letter of Intent to merge with Biosphere Technologies Inc.			May 31, 1995	585
NeXstar receives patent allowance for tumor-targeting liposomes.			Apr 18, 1995	366
Natural Product beautifies breasts without dangers of silicone.			Apr 13, 1995	322
NeXstar Pharmaceuticals says AmBisome gains marketing approval in Italy.			Mar 22, 1995	206
Genzyme begins phase II/III study of Argus Pharmaceuticals' TretinoinLF for Kaposi's sarcoma patients.			Dec 8, 1994	597
Liposome Technology's DOX-SL(TM) drug shown to be efficacious in treating AIDS patients with advanced Kaposi's sarcoma; Liposome Technology clinical investigators present clinical trial data at Glasgow AIDS meeting.			Nov 22, 1994	808
Gene courier targets skin-tumor cells.	Fackelmann, Kathy A.		Dec 4, 1993	654
The seeds of better chemotherapy?			Jan 5, 1991	574

Browse  Liposomes topic

Subtopics (9)

Articles

Browse Liposomes topic